Ticker
NWBOCompany Name
NORTHWEST BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
OTCDate | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -74.32M | $ -0.05 | 1 | 1.44B |
3/31/2025 | $ -76.96M | $ -0.06 | 1 | 1.36B |
12/31/2024 | $ -76.01M | $ -0.06 | 1 | 1.24B |
9/30/2024 | $ -67.95M | $ -0.05 | 1 | 1.26B |
6/30/2024 | $ -67.57M | $ -0.06 | 1 | 1.21B |
3/31/2024 | $ -64.53M | $ -0.05 | 1 | 1.19B |
12/31/2023 | $ -57.36M | $ -0.05 | 1 | 1.12B |
9/30/2023 | $ -66.76M | $ -0.06 | 1 | 1.13B |
6/30/2023 | $ -81.19M | $ -0.07 | 1 | 1.11B |
3/31/2023 | $ -96.28M | $ -0.09 | 1 | 1.07B |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: EBIT [ $ -234.72M ] / (Shares WA [ 747.75M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -0.31 ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.79K |
---|---|
min | $ -9.71 |
max | $ 10.76 |
average | $ 1.16 |
median | $ 0.39 |
std | $ 3.41 |